What Makes a Cup, a Cup? Generalizing Novel Words

April 17, 2024 updated by: Sarah Kucker, Oklahoma State University

Technological Timescales: Identifying the Impact of Digital Media on the Mechanisms of Word Learning. Aim 2: What Makes a Cup, a Cup? Generalizing Novel Words

The goal of this work is to address increasing concerns about young children's digital media exposure and language outcomes by testing how the times course of word learning unfolds in digital environments and the cascading impact of digital media on vocabulary outcomes. The findings will have important implications for understanding when and where optimal word learning from media can occur.

Study Overview

Detailed Description

The goal of the current proposal is to identify how digital media alters the mechanisms of word learning and subsequently impacts the lexical foundation on which a child's vocabulary is built. Specifically, the proposal aims to identify the impact of digital media on 1) the processes underlying real-time word learning, and 2) the processes of language generalization and vocabulary growth. Specific Aim 1 will use a novel word learning task to test children's ability to map and retain new words within and between digital media (2D images on a tablet) and real world objects (3D objects). Specific Aim 2 will probe children's novel label generalization abilities within and between 2D and 3D modalities using a novel noun generalization task. Further, individual differences in a child's prior technology experience will be measured and used to predict overall vocabulary as well as performance within and between each task. This Clinical Trial record focuses on Specific Aim 2.

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Oklahoma
      • Stillwater, Oklahoma, United States, 74078
        • Recruiting
        • Oklahoma State University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 2 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • between 18-30 months old

Exclusion Criteria:

  • diagnosed developmental delay or disorder
  • exposure to more than 25% of another language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: 3D-3D
All items presented in 3D form.
Experimental: 3D-2D
Initial exposure to items in 3D, generalization in 2D
Modality in which items will be presented (via tablet/digital media or as real object). 3D items initially and generalization as 2D
Other Names:
  • digital media modality
Experimental: 2D-3D
Initial exposure to items in 2D, generalization in 3D
Modality in which items will be presented (via tablet/digital media or as real object). 2D items initially and generalization as 3D
Other Names:
  • digital media modality
Experimental: 2D-2D
Initial exposure to items in 2D, generalization in 2D
Modality in which items will be presented (via tablet/digital media or as real object). 2D items initially and generalization as 2D
Other Names:
  • digital media modality

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Generalization performance
Time Frame: 1 minute
Accuracy on selecting the target item on novel noun generalization task, defined as percent of choices to the shape-matching item across all trials
1 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 7, 2022

Primary Completion (Estimated)

April 1, 2025

Study Completion (Estimated)

April 1, 2025

Study Registration Dates

First Submitted

June 29, 2022

First Submitted That Met QC Criteria

June 29, 2022

First Posted (Actual)

July 5, 2022

Study Record Updates

Last Update Posted (Actual)

April 19, 2024

Last Update Submitted That Met QC Criteria

April 17, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • AS-18-155A
  • R15HD101841 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Studies proposed will be registered under the Open Science Framework (OSF) and resulting findings shared with the academic community through open science initiatives, including OSF and the sharing of videos (when permission is granted) on Databrary.

IPD Sharing Time Frame

After completion of the project and for the duration allowed by the IRB.

IPD Sharing Access Criteria

Databrary authorized user

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Modality - 3D-2D

3
Subscribe